ES2057746T3 - Monoamidas de dtpa, agentes farmaceuticos que contienen estos compuestos, su utilizacion y procedimientos para su preparacion. - Google Patents

Monoamidas de dtpa, agentes farmaceuticos que contienen estos compuestos, su utilizacion y procedimientos para su preparacion.

Info

Publication number
ES2057746T3
ES2057746T3 ES91250089T ES91250089T ES2057746T3 ES 2057746 T3 ES2057746 T3 ES 2057746T3 ES 91250089 T ES91250089 T ES 91250089T ES 91250089 T ES91250089 T ES 91250089T ES 2057746 T3 ES2057746 T3 ES 2057746T3
Authority
ES
Spain
Prior art keywords
rest
group
sub
rent
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91250089T
Other languages
English (en)
Inventor
Heinz Dr Gries
Erich Dr Klieger
Bernd Dr Raduchel
Heribert Dr Schmitt-Willich
Hanns-Joachim Dr Weinmann
Hubert Dr Vogler
Gabriele D Schuhmann-Giampieri
Jurgen Dr Conrad
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Application granted granted Critical
Publication of ES2057746T3 publication Critical patent/ES2057746T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/003—Compounds containing elements of Groups 3 or 13 of the Periodic Table without C-Metal linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/12—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02—Iron compounds
    • C07F15/025—Iron compounds without a metal-carbon linkage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Pyrrole Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

COMPUESTOS DE FORMULA GENERAL I EN LA QUE Z ELEVADO 1 Y Z (AL CUADRADO) REPRESENTAN RESPECTIVAMENTE UN ATOMO DE HIDROGENO O EL RESTO SUB K CIFRAS 0 Y 1, Y R ES UN ATOMO DE HIDROGENO, UN RESTO ALQUILO DE C SUB 1 2 HIDROGENO, UN RESTO ALQUILO DE C SUB 1 NCILO, R (AL CUADRADO) REPRESENTA UN GRUPO ALQUILO DE HASTA 20 ATOMOS DE C, SATURADO, INSATURADO, DE CADENA LINEAL O RAMIFICADA O CICLICO, SUSTITUIDO EVENTUALMENTE POR UN GRUPO CARBOXILO O SULFONILO ESTERIFICADO CON UN RESTO ALQUILO DE C SUB 1 UB 6 O CON UN RESTO BENCILO; UN GRUPO ARILO O UN GRUPO ARALQUILO. R ELEVADO 3 REPRESENTA UN ATOMO DE HIDROGENO O UN GRUPO ALQUILO DE HASTA 20 ATOMOS DE C, SATURADO, INSATURADO, DE CADENA LINEAL O RAMIFICADA O CICLICO, SUSTITUIDO EVENTUALMENTE POR UN GRUPO CARBOXILO O SULFONILO ESTERIFICADO CON UN RESTO ALQUILO DE C SUB 1 UN GRUPO ARALQUILO, X REPRESENTA UN ATOMO DE HIDROGENO Y/O EL EQUIVALENTE DE UN ION METALICO DE UN ELEMENTO DE N CUADRADO) SEA UN ATOMO DE HIDROGENO, Y QUE -CUANDO N Y L SIGNIFICAN CADAUNO LA CIFRA 0 TE LA CIFRA 1, Y QUE ES DE DESEAR QUE EL RESTO DE LOS GRUPOS ACIDOS ESTE PRESENTE COMO ESTER O COMO AMIDA, ASI COMO EN FORMA DE SUS SALES CON BASES ORGANICAS Y/O INORGANICAS, AMINOACIDOS O AMIDAS DE AMINOACIDOS. ESTOS COMPUESTOS SON VALIOSAS SUSTANCIAS FARMACEUTICAS.
ES91250089T 1990-04-06 1991-04-05 Monoamidas de dtpa, agentes farmaceuticos que contienen estos compuestos, su utilizacion y procedimientos para su preparacion. Expired - Lifetime ES2057746T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4011684A DE4011684A1 (de) 1990-04-06 1990-04-06 Dtpa-monoamide, diese verbindungen enthaltende pharmazeutische mittel, ihre verwendung und verfahren zu deren herstellung

Publications (1)

Publication Number Publication Date
ES2057746T3 true ES2057746T3 (es) 1994-10-16

Family

ID=6404192

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91250089T Expired - Lifetime ES2057746T3 (es) 1990-04-06 1991-04-05 Monoamidas de dtpa, agentes farmaceuticos que contienen estos compuestos, su utilizacion y procedimientos para su preparacion.

Country Status (16)

Country Link
US (4) US5859214A (es)
EP (1) EP0450742B1 (es)
JP (1) JP2854159B2 (es)
AT (1) ATE108179T1 (es)
AU (1) AU644639B2 (es)
CA (1) CA2039846A1 (es)
DE (2) DE4011684A1 (es)
DK (1) DK0450742T3 (es)
ES (1) ES2057746T3 (es)
FI (1) FI911646L (es)
HU (1) HUT57180A (es)
IE (1) IE65923B1 (es)
NO (1) NO180582C (es)
NZ (1) NZ237711A (es)
PT (1) PT97263B (es)
ZA (1) ZA912550B (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4011684A1 (de) * 1990-04-06 1991-10-10 Schering Ag Dtpa-monoamide, diese verbindungen enthaltende pharmazeutische mittel, ihre verwendung und verfahren zu deren herstellung
WO1994001393A1 (fr) * 1992-07-03 1994-01-20 The Green Cross Corporation Nouveau chelateur, complexe compose dudit chelateur et d'un atome metallique, et agent diagnostique renfermant ledit complexe
US6875864B2 (en) 1991-08-01 2005-04-05 Bracco International B.V. Aminocarboxylate ligands having substituted aromatic amide moieties
AU5360994A (en) * 1992-10-13 1994-05-09 Mallinckrodt Medical, Inc. Novel compositions for magnetic resonance imaging
ES2140469T3 (es) * 1992-10-14 2000-03-01 Nycomed Imaging As Composiciones y metodos terapeuticos y de diagnostico por obtencion de imagenes.
WO1994009056A1 (en) * 1992-10-14 1994-04-28 Sterling Winthrop Inc. Chelating polymers
US5817292A (en) * 1992-10-14 1998-10-06 Nycomed Imaging As MR imaging compositions and methods
DE4317588C2 (de) * 1993-05-24 1998-04-16 Schering Ag Fluorhaltige makrocyclische Metallkomplexe, Verfahren zu ihrer Herstellung, sowie ihre Verwendung
DE4318369C1 (de) * 1993-05-28 1995-02-09 Schering Ag Verwendung von makrocyclischen Metallkomplexen als Temperatursonden
JP3878208B2 (ja) * 1994-04-08 2007-02-07 ブラッコ インターナショナル ベスローテン フェンノートシャップ 芳香族アミド化合物およびそれらのキレート
US5582814A (en) * 1994-04-15 1996-12-10 Metasyn, Inc. 1-(p-n-butylbenzyl) DTPA for magnetic resonance imaging
US5672335A (en) * 1994-11-30 1997-09-30 Schering Aktiengesellschaft Use of metal complexes as liver and gallbladder X-ray diagnostic agents
AU4173896A (en) * 1994-11-30 1996-06-19 Schering Aktiengesellschaft Use of chelate compounds as diagnostic agents in the x-ray examination of liver and bile ducts
TW319763B (es) 1995-02-01 1997-11-11 Epix Medical Inc
DE19507822B4 (de) * 1995-02-21 2006-07-20 Schering Ag Substituierte DTPA-Monoamide der zentralen Carbonsäure und deren Metallkomplexe, diese Komplexe enthaltende pharmazeutische Mittel, deren Verwendung in der Diagnostik und Therapie sowie Verfahren zur Herstellung der Komplexe und Mittel
DE19507819A1 (de) * 1995-02-21 1996-08-22 Schering Ag DTPA-Monoamide der zentralen Carbonsäure und deren Metallkomplexe, diese Komplexe enthaltende pharmazeutische Mittel, deren Verwendung in der Diagnostik und Therapie sowie Verfahren zur Herstellung der Komplexe und Mittel
DE19507820A1 (de) * 1995-02-21 1996-08-22 Schering Ag Neuartig substituierte DTPA-Derivate, deren Metallkomplexe, diese Komplexe enthaltende pharmazeutische Mittel, deren Verwendung in der Diagnostik, sowie Verfahren zur Herstellung der Komplexe und Mittel
IL117200A0 (en) * 1995-02-21 1996-06-18 Schering Ag Diethylenetriamine-pentaacetic acid monoamide derivatives pharmaceutical compostions containing the same and processes for the preparation thereof
DE19646762B4 (de) * 1996-11-04 2004-05-13 Schering Ag Verwendung von Metallverbindungen zur Herstellung von Mitteln zur Strahlentherapie von Tumoren
EP0953360B1 (en) * 1998-03-24 2004-05-26 Council of Scientific and Industrial Research Technetium-99m radiolabelled diethylene triamine pentaacetic acid diester and process for the preparation of technetium-99m diethylene triamine penta-acetic acid diester
GB9806530D0 (en) 1998-03-26 1998-05-27 Glaxo Group Ltd Inflammatory mediator
GB9823175D0 (en) * 1998-10-22 1998-12-16 Nycomed Imaging As Compound
CN101010107A (zh) * 2004-08-26 2007-08-01 马林克罗特公司 监测肾功能的发光金属络合物
FI20065030L (fi) * 2006-01-17 2007-07-18 Wallac Oy Neutraaliset leimausreagenssit ja niistä johdetut konjugaatit
WO2008022263A2 (en) * 2006-08-17 2008-02-21 Epix Pharmaceuticals, Inc. Methods for lymph system imaging
CN102171384B (zh) * 2008-05-28 2013-12-25 乔治洛德方法研究和开发液化空气有限公司 碳化硅基抗反射涂层
CN102549438B (zh) 2009-09-24 2014-10-29 国家健康与医学研究院 Fkbp52-tau相互作用作为新颖治疗靶点用于治疗涉及tau机能失调的神经障碍
EP2710381A2 (en) 2011-05-16 2014-03-26 Institut National de la Sante et de la Recherche Medicale (INSERM) Methods for screening substances capable of modulating the replication of an influenza virus
WO2014053871A1 (en) 2012-10-04 2014-04-10 INSERM (Institut National de la Santé et de la Recherche Médicale) A method for screening a compound capable of inhibiting the notch1 transcriptional activity
US20170051062A1 (en) 2014-02-18 2017-02-23 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods and Pharmaceutical Compositions for the Treatment of Diseases Mediated by the NRP-1/OBR Complex Signaling Pathway
ES2796857T3 (es) 2014-04-17 2020-11-30 Inst Nat Sante Rech Med Polipéptidos y usos de los mismos para reducir la motilidad celular mediada por CD95
KR20190135500A (ko) * 2017-04-27 2019-12-06 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 개질된 mri 조영제 및 이의 용도
US11008354B2 (en) * 2018-05-24 2021-05-18 The Texas A&M University System Chiral solvating agents
WO2020144324A1 (en) 2019-01-11 2020-07-16 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for screening inhibitors against chikungunya virus and for determining whether subjects are predisposed to infection by said virus
CN115043747B (zh) * 2022-08-15 2022-11-25 康瑞鑫(天津)药物研究院有限公司 卡洛酸三钠的析晶方法及制备的卡洛酸三钠晶体

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4352751A (en) * 1979-09-10 1982-10-05 Analytical Radiation Corporation Species-linked diamine triacetic acids and their chelates
US4647447A (en) * 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
US4957939A (en) * 1981-07-24 1990-09-18 Schering Aktiengesellschaft Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging
DE3324235A1 (de) * 1983-07-01 1985-01-10 Schering AG, 1000 Berlin und 4709 Bergkamen Neue komplexbildner, komplexe und komplexsalze
US4687659A (en) * 1984-11-13 1987-08-18 Salutar, Inc. Diamide-DTPA-paramagnetic contrast agents for MR imaging
US4859451A (en) * 1984-10-04 1989-08-22 Salutar, Inc. Paramagnetic contrast agents for MR imaging
US5087439A (en) * 1984-11-13 1992-02-11 Salutar, Inc. Paramagnetic metal-diethylenetriamine-pentaacetic acid partial amide complexes for magnetic resonance imaging
US4826673A (en) * 1985-01-09 1989-05-02 Mallinckrodt, Inc. Methods and compositions for enhancing magnetic resonance imaging
GB8610551D0 (en) * 1986-04-30 1986-06-04 Hoffmann La Roche Polypeptide & protein derivatives
US5039512A (en) * 1986-08-04 1991-08-13 Salutar, Inc. NMR imaging with paramagnetic polyvalent metal salts of poly-(acid-alkylene-amino)-alkanes
AU608759B2 (en) * 1986-08-04 1991-04-18 Amersham Health Salutar Inc NMR imaging with paramagnetic polyvalents metal salts of poly-(acid-alkylene-amido)-alkanes
US5219553A (en) * 1986-08-04 1993-06-15 Salutar, Inc. Composition of a n-carboxymethylated tetraazacyclododecane chelating agent, a paramagnetic metal and excess calcium ions for MRI
IL83966A (en) * 1986-09-26 1992-03-29 Schering Ag Amides of aminopolycarboxylic acids and pharmaceutical compositions containing them
DE3640708C2 (de) * 1986-11-28 1995-05-18 Schering Ag Verbesserte metallhaltige Pharmazeutika
US5693309A (en) 1987-03-31 1997-12-02 Schering Aktiengesellschaft Substituted complexing agents, complexes, and complex salts, processes for their production, and pharmaceuticals containing same
DE3710730A1 (de) * 1987-03-31 1988-10-20 Schering Ag Substituierte komplexbildner, komplexe und komplexsalze, verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel
US4994259A (en) * 1987-05-08 1991-02-19 Salutar, Inc. Improvement in the method of NMR imaging employing a manganese II chelates of N,N'-bis[pyridoxal-alkylene (or cycloalkylene) (or arylene)]-N,N'-diacetic acid derivatives
JP2833766B2 (ja) * 1987-07-16 1998-12-09 ニユコメド・アクシエセルカペト アミノポリカルボン酸およびその誘導体
US5399340A (en) * 1987-09-24 1995-03-21 Schering Aktiengesellschaft Use of amide complex compounds
US5137711A (en) 1988-07-19 1992-08-11 Mallickrodt Medical, Inc. Paramagnetic dtpa and edta alkoxyalkylamide complexes as mri agents
HUT59014A (en) 1988-09-27 1992-04-28 Salutar Inc Process for producing diagnostic compositions comprising chelates
US5198426A (en) 1988-12-30 1993-03-30 Warner-Lambert Company Renin inhibitors containing c-terminal dihydroxy amides
GB8900719D0 (en) * 1989-01-13 1989-03-08 Nycomed As Compounds
US5011925A (en) * 1989-03-09 1991-04-30 Mallinckrodt, Inc. Morpholinoamido EDTA derivatives
US5384108A (en) * 1989-04-24 1995-01-24 Mallinckrodt Medical, Inc. Magnetic resonance imaging agents
US6039931A (en) 1989-06-30 2000-03-21 Schering Aktiengesellschaft Derivatized DTPA complexes, pharmaceutical agents containing these compounds, their use, and processes for their production
DE3922005A1 (de) * 1989-06-30 1991-01-10 Schering Ag Derivatisierte dtpa-komplexe, diese verbindungen enthaltende pharmazeutische mittel, ihre verwendung und verfahren zu deren herstellung
US5087440A (en) * 1989-07-31 1992-02-11 Salutar, Inc. Heterocyclic derivatives of DTPA used for magnetic resonance imaging
GB8923843D0 (en) * 1989-10-23 1989-12-13 Salutar Inc Compounds
US5843399A (en) * 1990-04-06 1998-12-01 Schering Aktiengesellschaft DTPA monoamides for MRI
DE4011684A1 (de) * 1990-04-06 1991-10-10 Schering Ag Dtpa-monoamide, diese verbindungen enthaltende pharmazeutische mittel, ihre verwendung und verfahren zu deren herstellung
US5077037A (en) * 1990-08-03 1991-12-31 Mallinckrodt Medical, Inc. Novel compositions for magnetic resonance imaging
WO1994001393A1 (fr) * 1992-07-03 1994-01-20 The Green Cross Corporation Nouveau chelateur, complexe compose dudit chelateur et d'un atome metallique, et agent diagnostique renfermant ledit complexe
JP3215457B2 (ja) 1991-08-05 2001-10-09 株式会社ブリヂストン 氷雪上性能の改善されたゴム製品およびその製造方法
US5330743A (en) * 1992-11-12 1994-07-19 Magnetic Research, Inc. Aminosaccharide contrast agents for magnetic resonance images

Also Published As

Publication number Publication date
DK0450742T3 (da) 1994-11-07
IE65923B1 (en) 1995-11-29
IE911155A1 (en) 1991-10-09
US20030202943A1 (en) 2003-10-30
EP0450742A1 (de) 1991-10-09
ZA912550B (en) 1992-01-29
DE59102092D1 (de) 1994-08-18
US5859214A (en) 1999-01-12
FI911646A0 (fi) 1991-04-05
FI911646A7 (fi) 1991-10-07
US7074387B2 (en) 2006-07-11
FI911646L (fi) 1991-10-07
DE4011684A1 (de) 1991-10-10
AU7418691A (en) 1991-10-10
PT97263A (pt) 1992-01-31
EP0450742B1 (de) 1994-07-06
US6287538B1 (en) 2001-09-11
JPH0665174A (ja) 1994-03-08
NO180582B (no) 1997-02-03
ATE108179T1 (de) 1994-07-15
PT97263B (pt) 1998-08-31
JP2854159B2 (ja) 1999-02-03
US6565830B1 (en) 2003-05-20
NO911345D0 (no) 1991-04-05
CA2039846A1 (en) 1991-10-07
NO911345L (no) 1991-10-07
AU644639B2 (en) 1993-12-16
HU911126D0 (en) 1991-10-28
HUT57180A (en) 1991-11-28
NO180582C (no) 1997-05-14
NZ237711A (en) 1993-12-23

Similar Documents

Publication Publication Date Title
ES2057746T3 (es) Monoamidas de dtpa, agentes farmaceuticos que contienen estos compuestos, su utilizacion y procedimientos para su preparacion.
ES2128307T3 (es) Derivados de 1,4,7,10-tetraaza-ciclododecano monosustituidos en n, procedimiento para su preparacion y agentes farmaceuticos que los contienen.
ES8406423A1 (es) Procedimiento para la preparacion de derivados de amino acidos, de efecto edulcorante
ES2032596T3 (es) Composiciones inhibidoras de corrosion.
ES8105971A1 (es) Procedimiento para la obtencion de muramilpeptidos
ES8608480A1 (es) Procedimiento perfeccionado para la fabricacion de derivadosde amidas organicas de lipidos nitrogenados
ES8103753A1 (es) Procedimiento para la preparacion de acidos 3-cefem-4-carbo-xilicos sustituidos en la posicion 7
ES2113918T3 (es) Compuestos macrociclicos formadores de complejos con polimeros, sus complejos, procedimiento para su preparacion y agentes farmaceuticos que los contienen.
ES8604548A1 (es) Procedimiento para preparar nuevos derivados de acidos feni-laceticos
ES2032456T3 (es) Procedimiento para preparar derivados de 1,2,5,6-tetrahidropiridin-3-carboxaldehido-oxima.
ES8401025A1 (es) Procedimiento para la obtencion de acidos 1-carboxi-(azaalcanoil o azaaralcanoil)-indolin-2-carboxilicos.
ES470961A1 (es) Procedimiento para la obtencion de lipopeptidos
ES463409A1 (es) Procedimiento para la preparacion de nuevas fluoracil-resor-cinas sustituidas.
ES2071666T3 (es) Derivados de pirazoloisoquinolina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ES2059366T3 (es) Compuestos macrolidos.
ES8706714A1 (es) Procedimiento para la preparacion de derivados de 13beta-alquil-milbemicina
ES2039313T3 (es) Nuevos derivados de mediadores endogenos, sus sales, procedimiento de preparacion, aplicaciones, y composiciones que los contienen.
MX174285B (es) Agente de conservacion para plantas
ES8200122A1 (es) Un metodo para la preparacion de 17,21-diesteres de 6alfa- 9alfa-didluoro-16-metil-prednisolona
ES473464A1 (es) Procedimiento para la preparacion de nuevos derivados de 5,-11-dihidro-6h-pirido (2,3-b)(1,4)benzodiazepin-6-ona.
ES8403127A1 (es) Procedimiento para la preparacion de derivados de eburnamonina.
ES8405013A1 (es) Procedimiento para preparar derivados de tieno-tiazol
MX3330E (es) Procedimiento para la preparacion de 9-alcohilamino-eritromicinas y sus sales
ES2117701T3 (es) 2,4-dialquil-6-sec-alquilfenoles.
ES2038776T3 (es) Procedimiento de preparacion de derivados de la oxima del 1,2,5,6-tetrahidropiridin-3-carboxaldehido.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 450742

Country of ref document: ES